Last updated on May 2020

A Study to Evaluate the Efficacy Safety and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)

Brief description of study

This study is designed to evaluate the efficacy, safety, and pharmacokinetics of UTTR1147A compared with vedolizumab and with placebo in the treatment of participants with moderate to severe UC. This study will consist of two parts, Part A and Part B. Part A will test the induction of clinical remission and Part B will test the durability of clinical remission.

Clinical Study Identifier: NCT03558152

Find a site near you

Start Over

Care Access Research

San Pablo, CA United States
  Connect »

University of Miami

Miami, FL United States
  Connect »

Clin. Rsrch Inst. of Michigan

Chesterfield, MI United States
  Connect »

Southtowns Gastroenterology, PLLC

Orchard Park, NY United States
  Connect »

VA Medical Center - Syracuse

Syracuse, NY United States
  Connect »

Carolina Digestive Diseases

Greenville, NC United States
  Connect »

Gastro One

Germantown, TN United States
  Connect »

BI Research Center

Houston, TX United States
  Connect »

MC Medica Plus

Veliko Tarnovo, Bulgaria
  Connect »

ETG Kielce

Kielce, Poland
  Connect »

ETZ TweeSteden

Tilburg, Netherlands
  Connect »

QWay Research

Hialeah, FL United States
  Connect »

Atlantic Health System

Morristown, NJ United States
  Connect »

Saint Martyr Elizabeth City Hospital

Sankt-peterburg, Russian Federation
  Connect »

Kuban State Medical University

Krasnodar, Russian Federation
  Connect »

Medical University Reaviz

Samara, Russian Federation
  Connect »

Kings College Hospital

London, United Kingdom
  Connect »

Royal Victoria Infirmary

Newcastle upon Tyne, United Kingdom
  Connect »

ICS ARENSIA Exploratory Medicine

Chisinau, Moldova, Republic of
  Connect »

Klimed Marek Klimkiewicz

Piotrków Trybunalski, Poland
  Connect »


Wrocław, Poland
  Connect »